
Immune checkpoint inhibitors are transformative new immunotherapeutics that can unleash the body’s immune system to attack and destroy cancer cells.

Early detection of cancer using artificial intelligence–powered devices and software is a rapidly evolving research area with exciting new developments.
Learn More
Research-driven advances in identifying genetic mutations that fuel tumor growth have set the stage for a new era of precision medicine.
Learn More
In the United States, 40 percent of all cancers are associated with modifiable risk factors.
Learn More